GlaxoSmithKline S.A.E Market Cap

GlaxoSmithKline S.A.E has a market cap or net worth of 4.05 billion as of August 15, 2025. Its market cap has increased by 66.37% in one year.

Market Cap

4.05B

Enterprise Value

3.81B

Revenue

3.52B

Ranking

n/a

PE Ratio

27.64

Stock Price

48.48

Market Cap Chart

Since August 23, 2005, GlaxoSmithKline S.A.E's market cap has increased from 569.45M to 4.05B, an increase of 610.99%. That is a compound annual growth rate of 10.31%.

Market Cap History

Date	Market Cap	% Change
Aug 14, 2025	4.05B	34.67%
Dec 31, 2024	3.01B	1.27%
Dec 31, 2023	2.97B	-6.84%
Dec 29, 2022	3.19B	23.58%
Dec 30, 2021	2.58B	82.08%
Dec 31, 2020	1.42B	-14.17%
Dec 31, 2019	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Commercial International Bank Egypt (CIB) S.A.E.	303.86B
El Sewedy Electric Company	169.44B
Talaat Moustafa Group Holding	115.43B
Eastern Company S.A.E	114.81B
Misr Fertilizer Production Company	83.78B
Telecom Egypt Company	76.48B
Egypt Aluminum	67.40B
Abu Qir Fertilizers and Chemical Industries Co. (S.A.E.)	66.39B

Market Cap Rankings